We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
301
Marsh
MRSH
$91.7B
$2.37M 0.06%
42,638
+10,036
+31% +$553K
GPT
302
DELISTED
Gramercy Property Trust
GPT
$2.36M 0.06%
+101,782
New +$6.34M
EFA icon
303
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
$2.35M 0.06%
+40,000
New +$2.41M
OB
304
DELISTED
Onebeacon Insurance Group Ltd
OB
$2.35M 0.06%
189,305
-80,000
-30% -$1.1M
VEON icon
305
VEON
VEON
$3.57B
$2.34M 0.06%
28,551
+28,125
+6,602% +$2.54M
LIVN icon
306
LivaNova
LIVN
$4.51B
$2.34M 0.06%
+39,414
New +$2.39M
CSCO icon
307
PUT
Cisco
CSCO
$456B
$2.33M 0.06%
86,000
+24,000
+39% +$662K
TAP icon
308
Molson Coors Class B
TAP
$7.97B
$2.33M 0.06%
24,837
+11,875
+92% +$1.07M
CNQ icon
309
Canadian Natural Resources
CNQ
$92.2B
$2.33M 0.06%
220,501
+170,726
+343% +$1.91M
LUMN icon
310
Lumen
LUMN
$6.38B
$2.33M 0.06%
92,435
+63,661
+221% +$1.71M
LM
311
DELISTED
Legg Mason, Inc.
LM
$2.32M 0.06%
59,129
+38,081
+181% +$1.63M
INTC icon
312
PUT
Intel
INTC
$435B
$2.3M 0.06%
66,800
-59,600
-47% -$2.01M
CYH icon
313
Community Health Systems
CYH
$393M
$2.29M 0.06%
104,356
+20,073
+24% +$518K
PNC icon
314
CALL
PNC Financial Services
PNC
$100B
$2.29M 0.06%
24,000
+8,000
+50% +$743K
PNC icon
315
PUT
PNC Financial Services
PNC
$100B
$2.29M 0.06%
24,000
+8,000
+50% +$743K
REGN icon
316
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
$2.28M 0.06%
4,200
-21,700
-84% -$11.8M
STZ icon
317
PUT
Constellation Brands
STZ
$22.5B
$2.28M 0.06%
+16,000
New +$2.2M
CAH icon
318
Cardinal Health
CAH
$54.5B
$2.28M 0.06%
25,496
-12,076
-32% -$1.03M
TRP icon
319
TC Energy
TRP
$70.5B
$2.23M 0.06%
68,372
+60,348
+752% +$2M
RCL icon
320
CALL
Royal Caribbean
RCL
$86.5B
$2.23M 0.06%
22,000
+10,000
+83% +$952K
RCL icon
321
PUT
Royal Caribbean
RCL
$86.5B
$2.23M 0.06%
22,000
+10,000
+83% +$952K
AXP icon
322
CALL
American Express
AXP
$227B
$2.23M 0.06%
32,000
+10,000
+45% +$728K
AXP icon
323
PUT
American Express
AXP
$227B
$2.23M 0.06%
32,000
+12,000
+60% +$873K
XOM icon
324
ExxonMobil
XOM
$634B
$2.23M 0.06%
28,547
+21,574
+309% +$1.72M
SPR
325
DELISTED
Spirit AeroSystems
SPR
$2.22M 0.06%
44,349
+6,955
+19% +$355K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.